FEATURED

Early-Stage Breast CA in Black Women

Even with early diagnosis, there appears to be a disproportionate toll from breast cancer in black women.

ESMO RCC Practice Guidelines

ESMO guidelines account for new criteria in renal cell carcinoma, providing guidance on recommended therapies.

Causes of Anxiety in Lymphoma

Non-Hodgkin lymphoma relapse is not a cause for increased anxiety if recurrence is quickly addressed with well tolerated therapy.

Drug Showcase: KYPROLIS (carfilzomib)

This slideshow reviews drug information for KYPROLIS (carfilzomib), indicated for refractory multiple myeloma.

CancerLinQ Set to Launch in 2015

CancerLinQ will go live later this year, ushering in what they described as a transformative era of big data–driven precision cancer care.

Multiple myeloma: Optimal management

New strategies to combat myeloma incorporate risk stratification.

ASCO: Cancer Advance of the Year

The transformation of the treatment of chronic lymphocytic leukemia wins the Society's accolade.

Genetic, Metabolic Factors in RCC

Recent studies reveal the mechanisms underlying RCC and suggest new therapeutic targets.

Reflecting on Treatment for Leukemia

Dr. Cunningham: Leukemia is sometimes a solid and invasive neoplasm, but this is forgotten when leukemia is viewed as only a "liquid" cancer.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Viewpoints

Black Women Disproportionately Affected by Early-Stage Breast Cancer

Black Women Disproportionately Affected by Early-Stage Breast Cancer

Even with early diagnosis, there appears to be a disproportionate toll from breast cancer in black women.

Surveillance Until Rituximab Retreatment Does Not Increase Anxiety in Non-Hodgkin Lymphoma

Surveillance Until Rituximab Retreatment Does Not Increase Anxiety in Non-Hodgkin Lymphoma

Non-Hodgkin lymphoma relapse is not a cause for increased anxiety if recurrence is quickly addressed with well tolerated therapy.

Feature Articles

European Society for Medical Oncology (ESMO) Renal Cell Carcinoma Practice Guidelines

European Society for Medical Oncology (ESMO) Renal Cell Carcinoma Practice Guidelines

ESMO guidelines account for new criteria in renal cell carcinoma, providing guidance on recommended therapies as new data and kinase inhibitors have emerged.

Multiple myeloma: Optimal management and long-term disease control

Multiple myeloma: Optimal management and long-term disease control

[Blood and Lymphatic Cancer: Targets and Therapy] Myeloma displays considerable heterogeneity and, over time, control of disease can be lost. New strategies to combat myeloma incorporate risk stratification to provide more individualized therapy.

Featured Videos

Fall Digital Issue

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs